CorMedix (CRMD) Operating Leases (2019 - 2025)

CorMedix has disclosed Operating Leases across 7 years of filings, most recently posting $2.3 million for Q4 2025.

• Operating Leases for Q4 2025 came in at $2.3 million, up 545.56% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.3 million (up 545.56% YoY), and the FY2025 annual result was $2.3 million, up 545.56% from the prior year.
• Operating Leases came in at $2.3 million for Q4 2025 at CorMedix, down from $2.4 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $2.4 million in Q3 2025 to a low of $304092.0 in Q1 2025.
• The 5-year median for Operating Leases is $685289.5 (2022), against an average of $803047.6.
• Across the five-year window, Operating Leases surged 47205.04% in 2021 and sank 44.1% in 2024, its largest moves.
• CorMedix's Operating Leases stood at $802433.0 in 2021, then declined by 16.8% to $667632.0 in 2022, then retreated by 22.56% to $517000.0 in 2023, then plunged by 32.5% to $349000.0 in 2024, then soared by 545.56% to $2.3 million in 2025.
• The last three Operating Leases figures came in at $2.3 million (Q4 2025), $2.4 million (Q3 2025), and $435000.0 (Q2 2025), per Business Quant data.